Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
AIMS: Because low-grade inflammation may play a role in the pathogenesis of coronary heart disease (CHD), and pro-inflammatory cytokines govern inflammatory cascades, this study aimed to assess the associations of several pro-inflammatory cytokines and CHD risk in a new prospective study, including meta-analysis of prospective studies. METHODS AND RESULTS: Interleukin-6 (IL-6), IL-18, matrix metalloproteinase-9 (MMP-9), soluble CD40 ligand (sCD40L), and tumour necrosis factor-α (TNF-α) were measured at baseline in a case-cohort study of 1514 participants and 833 incident CHD events within population-based prospective cohorts at the Danish Research Centre for Prevention and Health. Age- and sex-adjusted hazard ratios (HRs) for CHD per 1-SD higher log-transformed baseline levels were: 1.37 (95% CI: 1.21-1.54) for IL-6, 1.26 (1.11-1.44) for IL-18, 1.30 (1.16-1.46) for MMP-9, 1.01 (0.89-1.15) for sCD40L, and 1.13 (1.01-1.27) for TNF-α. Multivariable adjustment for conventional vascular risk factors attenuated the HRs to: 1.26 (1.08-1.46) for IL-6, 1.12 (0.95-1.31) for IL-18, 1.21 (1.05-1.39) for MMP-9, 0.93 (0.78-1.11) for sCD40L, and 1.14 (1.00-1.31) for TNF-α. In meta-analysis of up to 29 population-based prospective studies, adjusted relative risks for non-fatal MI or CHD death per 1-SD higher levels were: 1.25 (1.19-1.32) for IL-6; 1.13 (1.05-1.20) for IL-18; 1.07 (0.97-1.19) for MMP-9; 1.07 (0.95-1.21) for sCD40L; and 1.17 (1.09-1.25) for TNF-α. CONCLUSIONS: Several different pro-inflammatory cytokines are each associated with CHD risk independent of conventional risk factors and in an approximately log-linear manner. The findings lend support to the inflammation hypothesis in vascular disease, but further studies are needed to assess causality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010 · cited 1×
“Atherosclerosis 2009 Jul;205(1):302-308.”
The Danish National Hospital Register. A valuable source of data for modern health sciences.
Andersen, T. F., Madsen, M., Jørgensen, J. O. L., Mellemkjoer, L., & Olsen, J. H. (1999) · PubMed · Cited by 2,026
A case-cohort design for epidemiologic cohort studies and disease prevention trials
PRENTICE, R. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.1 · Cited by 1,439
Rouse, D. (1990) · Journal of Clinical Pathology · doi:10.1136/jcp.43.9.787-d · Cited by 1,179
(2012) · The Lancet · doi:10.1016/s0140-6736(12)60110-x · Cited by 1,146
Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.101.18.2149 · Cited by 934
Therapeutic antibodies for autoimmunity and inflammation
Chan, A. C., & Carter, P. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2761 · Cited by 837
Soluble CD40 Ligand in Acute Coronary Syndromes
Heeschen, C., Dimmeler, S., Hamm, C. W., van den Brand, M. J., Boersma, E., Zeiher, A. M., & Simoons, M. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022600 · Cited by 828
(2012) · The Lancet · doi:10.1016/s0140-6736(11)61931-4 · Cited by 823
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
Blankenberg, S., Rupprecht, H. J., Poirier, O., Bickel, C., Smieja, M., Hafner, G., Meyer, J., Cambien, F., & Tiret, L. (2003) · Circulation · doi:10.1161/01.cir.0000058700.41738.12 · Cited by 755
Analysis of Case-Cohort Designs
Barlow, W. E., Ichikawa, L., Rosner, D., & Izumi, S. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00102-x · Cited by 682
Danesh, J., Kaptoge, S., Mann, A. G., Sarwar, N., Wood, A., Angleman, S. B., Wensley, F., Higgins, J. P. T., Lennon, L., Eiriksdottir, G., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050078 · Cited by 676 · cited 2×
“Nat Rev Drug Discov 2010 Sep;9(9):703-718.”
Self-citationC Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC) (2011) · BMJ · doi:10.1136/bmj.d548 · Cited by 642
Inflammatory Mechanisms: The Molecular Basis of Inflammation and Disease
Libby, P. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00352.x · Cited by 596
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
Neurath, M. F., & Finotto, S. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.02.003 · Cited by 576
Dixon, W. G., Watson, K. D., Lunt, M., Hyrich, K. L., Silman, A. J., & Symmons, D. P. M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22809 · Cited by 562
Ridker, P. M., Howard, C. P., Walter, V., Everett, B., Libby, P., Hensen, J., & Thuren, T. (2012) · Circulation · doi:10.1161/circulationaha.112.122556 · Cited by 530
Madsen, M. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00591-7 · Cited by 460
Easton, D. F., Peto, J., & Babiker, A. G. A. G. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100703 · Cited by 433
The Danish registers of causes of death.
Juel, K., & Helweg‐Larsen, K. (1999) · PubMed · Cited by 411
Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE
Symmons, D. P. M., & Gabriel, S. E. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.75 · Cited by 406
Blankenberg, S., Luc, G., Ducimetière, P., Arveiler, D., Ferrières, J., Amouyel, P., Evans, A., Cambien, F., & Tiret, L. (2003) · Circulation · doi:10.1161/01.cir.0000099509.76044.a2 · Cited by 329
Role for TNF in atherosclerosis? Lessons from autoimmune disease
McKellar, G. E., McCarey, D. W., Sattar, N., & McInnes, I. B. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.57 · Cited by 295
RIDKER, P. M. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03404.x · Cited by 270
Averting inflammation by targeting the cytokine environment
Kopf, M., Bachmann, M. F., & Marsland, B. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2805 · Cited by 257
Chene, G., & Thompson, S. G. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008971 · Cited by 193
Joensen, A. M., Jensen, M. K., Overvad, K., Dethlefsen, C., Schmidt, E., Rasmussen, L., Tjønneland, A., & Johnsen, S. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.03.005 · Cited by 180
Kinlay, S., Schwartz, G. G., Olsson, A. G., Rifai, N., Sasiela, W. J., Szarek, M., Ganz, P., & Libby, P. (2004) · Circulation · doi:10.1161/01.cir.0000136588.62638.5e · Cited by 171
Navarro-Millán, I. Y., Singh, J. A., & Curtis, J. R. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.02.014 · Cited by 158
Fibrinogen and coronary heart disease: test of causality by ‘Mendelian randomization’
Keavney, B., Danesh, J., Parish, S., Palmer, A., Clark, S., Youngman, L., Delépine, M., Lathrop, M., Peto, R., & Collins, R. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl114 · Cited by 142
Self-citationSTABILITY OF INTERLEUKIN 6, SOLUBLE INTERLEUKIN 6 RECEPTOR, INTERLEUKIN 10 AND CC16 IN HUMAN SERUM
Kenis, G., Teunissen, C. E., Jongh, R. F. D., Bosmans, E., Steinbusch, H. W. M., & Maes, M. H. J. (2002) · Cytokine · doi:10.1006/cyto.2002.1961 · Cited by 127
The Fibrinogen Studies Collaboration (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl233 · Cited by 98
Plasma storage at −80 °C does not protect matrix metalloproteinase-9 from degradation
Rouy, D., Ernens, I., Jeanty, C., & Wagner, D. R. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.10.052 · Cited by 93
Jefferis, B. J. M. H., Whincup, P. H., Welsh, P. I., Wannamethee, S. G., Rumley, A., LENNON, L. T., Thomson, A. G., Lawlor, D. A., Carson, C., Ebrahim, S. B. J., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.08.018 · Cited by 82
Self-citationOsler, M., Linneberg, A., Glumer, C., & Jorgensen, T. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyq041 · Cited by 81
Self-citationSerum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men
Welsh, P. I., Whincup, P. H., Papacosta, O., Wannamethee, S. G., LENNON, L. T., Thomson, A. G., Rumley, A., & Lowe, G. D. O. (2008) · QJM · doi:10.1093/qjmed/hcn088 · Cited by 58
Self-citationHlatky, M. A., Ashley, E. A., Quertermous, T., Boothroyd, D. B., Ridker, P. M., Southwick, A. M., Myers, R., Iribarren, C., Fortmann, S. P., & Go, A. S. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.06.042 · Cited by 57
Gerdes, L. U., Brønnum‐Hansen, H., Madsen, M., Borch‐Johnsen, K., Jørgensen, T., Sjøl, A., & Schroll, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00193-6 · Cited by 47
Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease
Elliott, P. (2009) · JAMA · doi:10.1001/jama.2009.954 · Cited by 35
Woodward, M., Welsh, P. I., Rumley, A., Tunstall-Pedoe, H., & Lowe, G. D. O. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp115 · Cited by 29
Self-citationJefferis, B. J. M. H., Whincup, P. H., Welsh, P. I., Wannamethee, S. G., Rumley, A., Lawlor, D. A., Ebrahim, S. B. J., & Lowe, G. D. O. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04415.x · Cited by 25
Self-citationJefferis, B. J. M. H., Whincup, P. H., Welsh, P. I., Wannamethee, S. G., Rumley, A., LENNON, L. T., Thomson, A. G., Carson, C., Ebrahim, S. B. J., & Lowe, G. D. O. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.001 · Cited by 24
Self-citationGrisoni, M.-L., Proust, C., Alanne, M., DeSuremain, M., Salomaa, V. V., Kuulasmaa, K., Cambien, F., Nicaud, V., Wiklund, P.-G., Virtamo, J. R. K., et al. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-44 · Cited by 22
Cited by
Ridker, P. M. (2016) · Circulation Research · doi:10.1161/circresaha.115.306656 · Cited by 1,002
Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors
Fiuza-Luces, C., Santos-Lozano, A., Joyner, M., Carrera-Bastos, P., Picazo, O., Zugaza, J. L., Izquierdo, M., Ruilope, L. M., & Lucia, A. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0065-1 · Cited by 803
Ridker, P. M., Devalaraja, M., Baeres, F. M. M., Engelmann, M. D. M., Hovingh, G. K., Ivkovic, M., Lo, L., Kling, D., Pergola, P., Raj, D., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00520-1 · Cited by 737
Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease
Steven, S., Frenis, K., Oelze, M., Kalinovic, S., Kuntic, M., Bayo Jimenez, M. T., Vujacic-Mirski, K., Helmstädter, J., Kröller-Schön, S., Münzel, T., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7092151 · Cited by 708
Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Ridker, P. M., & Rane, M. (2021) · Circulation Research · doi:10.1161/circresaha.121.319077 · Cited by 691
Metadata
- Authors
- Kaptoge, S., Seshasai, S. R. K., Gao, P., Freitag, D. F., Butterworth, A. S., Borglykke, A., Di Angelantonio, E., Gudnason, V., Rumley, A., Lowe, G. D. O., Jorgensen, T., & Danesh, J.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-09-10
- Volume
- 35
- Issue
- 9
- Pages
- 578-589
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2163684054
- Cited by
- 666
- References
- 50
- FWCI
- 16.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.